Glaxosmithkline Pharmaceuticals consolidated net profit rises 167.09% in the September 2021 quarter
Sales rise 14.85% to Rs 1009.87 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 167.09% to Rs 204.24 crore in the quarter ended September 2021 as against Rs 76.47 crore during the previous quarter ended September 2020. Sales rose 14.85% to Rs 1009.87 crore in the quarter ended September 2021 as against Rs 879.32 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales1009.87879.32 15 OPM %27.3823.30 -PBDT291.14213.02 37 PBT273.54191.06 43 NP204.2476.47 167Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 29 2021 | 6:33 PM IST